Regulation of urocortin I and its related peptide urocortin II by inflammatory and oxidative stresses in HL-1 cardiomyocytes

Journal of Molecular Endocrinology

Volumn 42, Issue 6, 2009, Pages 479-489

  Ikeda, Kelichi ^a   Tojo, Katsuyoshi ^a   Inada, Yuri ^a   Takada, Yuko ^a   Sakamoto, Masaya ^a   Lam, May ^b   Claycomb, William C ^b   Tajima, Naoko ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PYRROLIDINE DITHIOCARBAMATE; TEMPOL; TUMOR NECROSIS FACTOR ALPHA; UROCORTIN I; UROCORTIN II;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STIMULATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HEART MUSCLE CELL; HEART STRESS; HL 1 CARDIOMYOCYTE; HORMONE RELEASE; INFLAMMATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUANTITATIVE STUDY; RADIOIMMUNOASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANGIOTENSIN II; ANIMALS; BASE SEQUENCE; CELL LINE; DNA PRIMERS; DNA, COMPLEMENTARY; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MYOCARDIUM; OXIDATIVE STRESS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UROCORTINS;

EID: 67649444343     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1677/JME-08-0151     Document Type: Article

References (45)

1. Akiyama Y 1995 TFSEARCH: searching transcription factor binding sites. Real World Computing Partnership, Japan (http://www.cbrc.jp/research/db/ TFSEARCHJ.html).
2. Asaba K, Makino S, Nishiyama M & Hashimoto K 2000 Regulation of type-2 corticotropin-releasing hormone receptor mRNA in rat heart by glucocorticoids and urocortin. Journal of Cardiovascular Pharmacology 36 493-497.
3. Boyd JH, Mathur S, Wang Y, Bateman RM & Walley KR 2006 Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response. Cardiovascular Research 72 384-393.
4. Brar BK, Chen A, Perrin MH & Vale W 2004a Specificity and regulation of extracellularly regulated kinase1/2 phosphorylation through corticotropin-releasing factor (CRF) receptors 1 and 2β by the CRF/urocortin family of peptides. Endocrinology 145 1718-1729.
5. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF & Vale W 2004b Urocortin-II and urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotropin releasing factor receptor type 2 in the murine heart. Endocrinology 145 24-35; discussion 21-23.
6. Chen A, Vaughan J & Vale WW 2003 Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways. Molecular Endocrinology 17 1622-1639.
7. Claycomb WC, Lanson NA Jr, Stallworth BS, Egeland DB, Delcarpio JB, Bahinski A & Izzo NJ Jr 1998 HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. PNAS 95 2979-2984.
8. Coste SC, Kesterson RA, Heldwein KA, Stevens SL, Heard AD, Hollis JH, Murray SE, Hill JK, Pantely GA, Hohimer AR et al. 2000 Abnormal adaptations to stress and impaired cardiovascular function in mice lacking corticotropin-releasing hormone receptor-2. Nature Genetics 24 403-409.
9. Coste SC, Heldwein KA, Stevens SL, Tobar-Dupres E & Stenzel-Poore MP 2001 IL-1α and TNFα down-regulate CRH receptor-2 mRNA expression in the mouse heart. Endocrinology 142 3537-3545.
10. Desaki M, Okazaki H, Sunazuka T, Omura S, Yamamoto K & Takizawa H 2004 Molecular mechanisms of anti-inflammatory action of erythromycin in human bronchial epithelial cells: possible role in the signaling pathway that regulates nuclear factor-κB activation. Antimicrobial Agents and Chemotherapy 48 1581-1585.
11. Hailman E, Lichenstein HS, Wurfel MM, Miller DS, Johnson DA, Kelley M, Busse LA, Zukowski MM & Wright SD 1994 Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. Journal of Experimental Medicine 179 269-277.
12. Heldwein KA, Duncan JE, Stenzel P, Rittenberg MB & Stenzel-Poore MP 1997 Endotoxin regulates corticotropin-releasing hormone receptor 2 in heart and skeletal muscle. Molecular and Cellular Endocrinology 131 167-172.
13. Honjo T, Inoue N, Shiraki R, Kobayashi S, Otsui K, Takahashi M, Hirata K, Kawashima S, Yokozaki H & Yokoyama M 2006 Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin. Journal of Vascular Research 43 131-138.
14. Ikeda K, Tojo K, Sato S, Ebisawa T, Tokudome G, Hosoya T, Harada M, Nakagawa O & Nakao K 1998 Urocortin, a newly identified corticotropin-releasing factor-related mammalian peptide, stimulates atrial natriuretic peptide and brain natriuretic peptide secretions from neonatal rat cardiomyocytes. Biochemical and Biophysical Research Communications 250 298-304.
15. Ikeda K, Tojo K, Tokudome G, Hosoya T, Tajima N, Oki Y, Asaba K, Hashimoto K, Harada M & Nako K 2001 Urocortin is an endogenous cardioprotective factor against negative effects of cytokines in the heart. Program of the 83rd Annual Meeting of The Endocrine Society, Denver, CO, p 419 (Abstract).
16. Ikeda K, Tojo K, Oki Y & Nakao K 2002 Urocortin has cell-proliferative effects on cardiac non-myocytes. Life Sciences 71 1929-1938.
17. Ikeda K, Tojo K, Tokudome G, Ohta M, Sugimoto K, Tamura T, Tajima N, Mochizuki S, Kawakami M & Hosoya T 2003 Cardiac expression of urocortin (Ucn) in diseased heart; preliminary results on possible involvement of Ucn in pathophysiology of cardiac diseases. Molecular and Cellular Biochemistry 252 25-32.
18. Ikeda K, Tojo K, Otsubo C, Udagawa T, Hosoya T, Tajima N, Nakao K & Kawamura M 2005a Effects of urocortin II on neonatal rat cardiac myocytes and non-myocytes. Peptides 26 2473-2481.
19. Ikeda K, Tojo K, Otsubo C, Udagawa T, Kumazawa K, Ishikawa M, Tokudome G, Hosoya T, Tajima N, Claycomb WC et al. 2005b 5-Hydroxytryptamine synthesis in HL-1 cells and neonatal rat cardiocytes. Biochemical and Biophysical Research Communications 328 522-525.
20. Ikeda K, Tojo K, Udagawa T, Otsubo C, Ishikawa M, Tokudome G, Hosoya T, Tajima N, Nakao K & Kawamura M 2008 Cellular physiology of rat cardiac myocytes in cardiac fibrosis: in vitro simulation using the cardiac myocyte/cardiac non-myocyte co-culture system. Hypertension Research 31 693-706.
21. Jefferson KK, Smith MF Jr & Bobak DA 1999 Roles of intracellular calcium and NF-κB in the Clostridium difficile toxin A-induced up-regulation and secretion of IL-8 from human monocytes. Journal of Immunology 163 5183-5191.
22. Karolchik D, Baertsch R, Diekhans M, Furey TS, Hinrichs A, Lu YT, Roskin KM, Schwartz M, Sugnet CW, Thomas DJ et al. 2003 The UCSC genome browser database. Nucleic Acids Research 31 51-54.
23. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM & Haussler D 2002 The human genome browser at UCSC. Genome Research 12 996-1006 (The software is available at http://genome.ucsc.edu/ index.html?org).
24. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T & Sasano H 2002 Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. Journal of Clinical Endocrinology and Metabolism 87 340-346.
25. Li C, Chen P, Vaughan J, Blount A, Chen A, Jamieson PM, Rivier J, Smith MS & Vale W 2003 Urocortin III is expressed in pancreatic β-cells and stimulates insulin and glucagon secretion. Endocrinology 144 3216-3224.
26. (t) Method. Methods 25 402-408.
27. Luft FC 2002 Angiotensin II, the AT2 receptor, and nuclear factor-κB activation. Kidney International 61 2272-2273.
28. Matsumori A, Yamada T, Suzuki H, Matoba Y & Sasayama S 1994 Increased circulating cytokines in patients with myocarditis and cardiomyopathy. British Heart Journal 72 561-566.
29. Miyachi Y, Yoshioka A, Imamura S & Niwa Y 1986 Effect of antibiotics on the generation of reactive oxygen species. Journal of Investigative Dermatology 86 449-453.
30. Moss AC, Anton P, Savidge T, Newman P, Cheifetz AS, Gay J, Paraschos S, Winter MW, Moyer MP, Karalis K et al. 2007 Urocortin II mediates pro-inflammatory effects in human colonocytes via corticotropin-releasing hormone receptor 2α. Gut 56 1210-1217.
31. Pañeda C, Winsky-Sommerer R, Boutrel B & de Lecea L 2005 The corticotropin-releasing factor-hypocretin connection: implications in stress response and addiction. Drug News & Perspectives 18 250-255.
32. Rozen S & Skaletsky H 2000 Primer3 on the WWW for general users and for biologist programmers. In Bioinformatics Methods and Protocols: Methods in Molecular Biology, pp 365-386. Eds S Krawetz & S Misener. Totowa: Humana Press (The software is available at http://frodo.wi.mit.edu/primer3/input.htm).
33. Saito T, Itoh H, Chun TH, Fukunaga Y, Yamashita J, Doi K, Tanaka T, Inoue M, Masatsugu K, Sawada N et al. 2001 Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells. American Journal of Physiology. Heart and Circulatory Physiology 281 H1364-H1371.
34. Sakai N, Mizuno R, Ono N, Kato H & Ohhashi T 2007 High oxygen tension constricts epineurial arterioles of the rat sciatic nerve via reactive oxygen species. American Journal of Physiology. Heart and Circulatory Physiology 293 H1498-H1507.
35. Saruta M, Takahashi K, Suzuki T, Torii A, Kawakami M & Sasano H 2004 Urocortin 1 in colonic mucosa in patients with ulcerative colitis. Journal of Clinical Endocrinology and Metabolism 89 5352-5361.
36. Sarzi-Puttini P, Atzeni F, Doria A, Iaccarino L & Turiel M 2005 Tumor necrosis factor-α, biologic agents and cardiovascular risk. Lupus 14 780-784.
37. Sassone-Corsi P 1998 Coupling gene expression to cAMP signalling: role of CREB and CREM. International Journal of Biochemistry and Cell Biology 30 27-38.
38. Sherman MP, Aeberhard EE, Wong VZ, Griscavage JM & Ignarro LJ 1993 Pyrrolidine dithiocarbamate inhibits induction of nitric oxide synthase activity in rat alveolar macrophages. Biochemical and Biophysical Research Communications 191 1301-1308.
39. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ & Klenk DC 1985 Measurement of protein using bicinchoninic acid. Analytical Biochemistry 150 76-85.
40. Takahashi K, Totsune K, Murakami O, Saruta M, Nakabayashi M, Suzuki T, Sasano H & Shibahara S 2004 Expression of urocortin III/stresscopin in human heart and kidney. Journal of Clinical Endocrinology and Metabolism 89 1897-1903.
41. Tu H, Kastin AJ, Bjorbaek C & Pan W 2007 Urocortin trafficking in cerebral microvessel endothelial cells. Journal of Molecular Neuroscience 31 171-181.
42. Uzuki M, Sasano H, Muramatsu Y, Totsune K, Takahashi K, Oki Y, Iino K & Sawai T 2001 Urocortin in the synovial tissue of patients with rheumatoid arthritis. Clinical Science 100 577-589.
43. Yasutomi M, Ohshima Y, Omata N, Yamada A, Iwasaki H, Urasaki Y & Mayumi M 2005 Erythromycin differentially inhibits lipopolysaccharide- or poly(I:C)-induced but not peptidoglycan-induced activation of human monocyte-derived dendritic cells. Journal of Immunology 175 8069-8076.
44. Yuan H, Perry CN, Huang C, Iwai-Kanai E, Carreira RS, Glembotski CC & Gottlieb RA 2009 LPS-induced autophagy is mediated by oxidative signaling in cardiomyocytes and is associated with cytoprotection. American Journal of Physiology. Heart and Circulatory Physiology 296 470-479.
45. Zhao L, Donaldson CJ, Smith GW & Vale WW 1998 The structures of the mouse and human urocortin genes (Ucn and UCN). Genomics 50 23-33.